Camp4 Therapeutics Corp
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | $3.5 | $0.7 | $0.3 | — |
| Operating income | -$52.6 | -$53.1 | -$51.9 | — |
| Net income | -$80.4 | -$51.8 | -$49.3 | — |
| Cash Flow Statement | ||||
| Free cash flow | -$29.8 | -$46.0 | -$44.8 | — |
Shares outstanding 62.8M · Free float 68.2%
Annual filing data through FY ended December 31, 2025; float as of October 4, 2026.